Browse Category

Mergers & Acquisitions 9 December 2025 - 12 December 2025

PetMed Express (PETS) Stock: $4 Takeover Proposal Sparks Surge — News, Forecasts, and Key Risks on Dec. 12, 2025

PetMed Express (PETS) Stock: $4 Takeover Proposal Sparks Surge — News, Forecasts, and Key Risks on Dec. 12, 2025

PetMed Express, Inc. — best known as PetMeds and the parent of PetCareRx — is back on traders' radars after a Singapore-based investor publicly disclosed an unsolicited proposal to take the online pet pharmacy private at $4.00 per share in cash . The news sent PETS sharply higher on Thursday, and the market is now trying to answer one question: Is the bid real enough to anchor the stock near $4, or is this a volatility event with meaningful execution risk? GlobeNewswire+ 2DRY+ 2
12 December 2025
··
Fairfax Leads Race for IDBI Bank Stake Sale: December-End Bid Deadline Near as Kotak Stays in the Fray

Fairfax Leads Race for IDBI Bank Stake Sale: December-End Bid Deadline Near as Kotak Stays in the Fray

New Delhi | December 12, 2025 — India’s long-delayed IDBI Bank stake sale has entered a decisive stretch, with Fairfax Financial emerging as the leading contender to acquire a controlling stake from the Government of India and Life Insurance Corporation of India, according to people familiar with the process. The race has effectively narrowed to two serious bidders—Fairfax and Kotak Mahindra Bank—as the deadline for financial bids approaches at the end of December, with some indications the timeline could spill into early January. The Economic Times+1
12 December 2025
··
Onto Innovation (ONTO) Stock on December 11, 2025: Latest Price, Q3 Earnings, Semilab Deal and 2026 Forecasts

Onto Innovation (ONTO) Stock on December 11, 2025: Latest Price, Q3 Earnings, Semilab Deal and 2026 Forecasts

Onto Innovation Inc., a mid‑cap supplier of semiconductor process control and inspection tools, is back in focus after a sharp intraday pullback, fresh short‑interest data and the recent closing of a $495 million acquisition that reshapes its growth outlook for 2026. Onto Innovation+1
11 December 2025
····
New Gold Inc (NGD) Stock: 201% Rally, $7 Billion Coeur Mining Buyout and December 2025 Analyst Outlook

New Gold Inc (NGD) Stock: 201% Rally, $7 Billion Coeur Mining Buyout and December 2025 Analyst Outlook

As of December 11, 2025, New Gold Inc has turned into one of the most closely watched gold miners on the market. The Canadian producer has enjoyed a 201% share‑price surge over the past year, posted record free cash flow, agreed to a $7 billion all‑stock acquisition by Coeur Mining, and now sits under an unusually bullish wall of analyst “Buy” ratings. Finimize+2Q4 CDN+2
11 December 2025
·····
Synopsys (SNPS) Soars on Record Q4 2025 Earnings, Ansys Integration and Nvidia Deal as Warner Bros. (WBD) Faces Downgrade

Synopsys (SNPS) Soars on Record Q4 2025 Earnings, Ansys Integration and Nvidia Deal as Warner Bros. (WBD) Faces Downgrade

Synopsys Inc. capped a pivotal fiscal 2025 with record fourth‑quarter and full‑year results on December 10, underscoring how its $35 billion acquisition of Ansys and a fresh $2 billion strategic partnership with Nvidia are reshaping the electronic design automation leader. Synopsys Investor Relations+2Synopsys Investor Relations+2
11 December 2025
····
ZIM Integrated Shipping (NYSE: ZIM) Stock: Buyout Bids, Big Dividends and a Volatile 2026 Outlook

ZIM Integrated Shipping (NYSE: ZIM) Stock: Buyout Bids, Big Dividends and a Volatile 2026 Outlook

ZIM Integrated Shipping Services Ltd. has turned into one of the most eventful tickers on the New York Stock Exchange heading into the end of 2025. The Israeli container carrier’s share price is hovering around $20 on 10 December 2025 after a powerful rebound of roughly 30–35% over the past month, driven by takeover speculation, a rich dividend stream and an escalating proxy fight around its board and strategy. Yahoo Finance
10 December 2025
··
Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax Société Anonyme is back in the spotlight on December 10, 2025, after its share price spiked again on fresh takeover speculation involving U.S. pharma giant Eli Lilly. The move caps an extraordinary year in which the French biotech has transformed from a relatively obscure name into a multibillion‑euro inflammatory bowel disease contender.Reuters+1
10 December 2025
····
CapitaLand Investment (SGX:9CI) Stock on 10 December 2025: Share Price, Merger Talk With Mapletree, Q3 Numbers and 2026 Outlook

CapitaLand Investment (SGX:9CI) Stock on 10 December 2025: Share Price, Merger Talk With Mapletree, Q3 Numbers and 2026 Outlook

Singapore – 10 December 2025 – CapitaLand Investment Limited is back in the spotlight as investors digest solid Q3 2025 business updates, fresh fund-raising milestones, and high‑profile merger speculation involving Mapletree Investments. At the same time, short‑term technical signals look cautious even as analysts continue to project double‑digit upside for the stock.Tiger Brokers+2The Straits Times+2
10 December 2025
··
Booking Holdings (BKNG) Stock Today: Nasdaq Conference, Allegiant Deal, Options Whales and Fresh Forecasts (Dec. 9, 2025)

Booking Holdings (BKNG) Stock Today: Nasdaq Conference, Allegiant Deal, Options Whales and Fresh Forecasts (Dec. 9, 2025)

Booking Holdings Inc. Common Stock is back in the spotlight on December 9, 2025, as investors digest a packed slate of catalysts: a high‑profile presentation at Nasdaq’s 53rd Investor Conference in London, a new airline partnership via Rocket Travel by Agoda, unusual options activity, and a wave of fresh institutional and analyst updates.
9 December 2025
···
1 … 5 6 7 8 9 … 20
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 BUY ON PULLBACK

Microsoft

NASDAQ: MSFT 94 / 100
#2 BUY

L3Harris Technologies

NYSE: LHX 90 / 100
#3 BUY

Xylem

NYSE: XYL 89 / 100
#4 BUY IN TRANCHES

Lam Research

NASDAQ: LRCX 87 / 100
#5 BUY ON WEAKNESS

GE HealthCare

NASDAQ: GEHC 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.